March 2021 Simoa® Publications:
Neurology: MS and TBI
Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis
Giarraputo J, et al.
J Neuroimmunol. 2021;354:577541
Multiple Sclerosis
A population-based study of head injury, cognitive function and pathological markers
James SN, et al.
Ann Clin Transl Neurol. 2021 Mar 11
Traumatic Brain Injury
The cholesterol autoxidation products, 7-ketocholesterol and 7β-hydroxycholesterol are associated with serum neurofilaments in multiple sclerosis
McComb M, et al.
Multiple sclerosis and related disorders. 2021;50:102864
Multiple Sclerosis
Temporal profile and utility of serum neurofilament light in a rat model of mild traumatic brain injury
O’Brien WT, et al.
Exp Neurol. 2021 Mar 13;341:113698
Traumatic Brain Injury
Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light
Orsi G, et al.
Multiple sclerosis and related disorders. 2021:102923
Multiple Sclerosis
Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging
Rahmanzadeh R, et al.
Brain, 2021;, awab088
Multiple Sclerosis
Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis
Raveney BJE, et al.
Proceedings of the National Academy of Sciences. 2021;118:e2021818118
Multiple Sclerosis
Comparison of neurofilament light chain results between two independent facilities
Sejbaek T, et al.
BMJ Neurol Open. 2020;2:e000063
Multiple Sclerosis
Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
Thebault S, et al.
Front. Neurosci., 25 March 2021
Multiple Sclerosis
March 2021 Simoa® Publications in Other Therapeutic Areas
